Cancer stem cells: Are they responsible for treatment failure?

Ruggero De Maria Marchiano, Marcello Maugeri-Saccà, Patrizia Vici, Luigi Di Lauro, Maddalena Barba, Carla Azzurra Amoreo, Enzo Gallo, Marcella Mottolese

Risultato della ricerca: Contributo in rivistaArticolo in rivista

12 Citazioni (Scopus)

Abstract

Overcoming resistance to standard anticancer treatments represents a significant challenge. The interest regarding cancer stem cells, a cellular population that has the ability to self-renew and to propagate the tumor, was prompted by experimental evidence delineating the molecular mechanisms that are selectively activated in this cellular subset in order to survive chemotherapy. This has also stimulated combination strategies aimed at rendering cancer stem cells vulnerable to anticancer agents. Moreover, cancer stem cells offer a unique opportunity for modeling human cancers in mice, thus emerging as a powerful tool for testing novel drugs and combinations in a simulation of human disease. These novel animal models may lay the foundation for a new generation of clinical trials aimed at anticipating the benefit to patients of anticancer therapies.
Lingua originaleEnglish
pagine (da-a)2033-2044
Numero di pagine12
RivistaFuture Oncology
Volume10
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Apoptotic pathways
  • CSC-derived xenografts
  • Cancer Research
  • Cancer stem cells
  • Chemotherapy
  • Clonal evolution
  • Differentiation
  • Dna damage repair
  • Hierarchical model
  • Oncology
  • Self-renewal pathways
  • Survival pathways

Fingerprint

Entra nei temi di ricerca di 'Cancer stem cells: Are they responsible for treatment failure?'. Insieme formano una fingerprint unica.

Cita questo